Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Pharma
Roche's cancer med Gazyva scores FDA nod in lupus nephritis
With the lupus treatment landscape poised for a shake-up, Roche is hitting the scene with a new green light for its blood cancer drug Gazyva.
Fraiser Kansteiner
Oct 20, 2025 10:15am
ESMO: Enhertu wields 2-fisted power in early breast cancer
Oct 18, 2025 10:30am
Big Pharma bets big on MASH with a new combo playbook
Oct 17, 2025 9:30am
Zenas gains MS hopeful in $2B deal with China's InnoCare
Oct 8, 2025 11:50am
Genentech awarded $124M in Cabilly patent dispute with Biogen
Oct 6, 2025 3:37pm
Jazz, Roche's small cell lung cancer combo snags FDA approval
Oct 3, 2025 10:00am
